ARVN Arvinas Holding

Arvinas Gives Back to Local Greater New Haven Community in Second Annual Impact Day

Arvinas Gives Back to Local Greater New Haven Community in Second Annual Impact Day

NEW HAVEN, Conn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that nearly 200 employees participated in the Company’s second annual “Arvinas Impact Day,” a company-wide community service day benefiting organizations in the Greater New Haven area.

"'Arvinas Impact Day' is a reflection of our company's unwavering dedication to community. It’s inspiring to see both local and remote colleagues transcend geographical boundaries to serve our community with passion and purpose,” said John Houston, Ph.D., chairperson, chief executive officer, and president at Arvinas. “Together, we’ve contributed to the expansion of important greater New Haven and youth science, technology, engineering, and math (STEM) initiatives while exemplifying Arvinas’ core value of community and our shared commitment to making a difference.”

Employees rolled up their sleeves and, through their collective efforts, helped make facility and grounds enhancements at a local non-profit organization, beautified the local environment with garbage pickup and clearing invasive species; prepared meals to be served to members of the New Haven Community; served as role models in a local school, helping to positively impact young people’s perceptions about the importance of education; and created STEM kits to be provided to foster youth across the country.

More specifically, Arvinas employees impacted the community through the following efforts:

  • Friends of East Rock Park: 25 Arvinas team members worked in East Rock Park to de-vine trees of an invasive species, nurture saplings, and remove trash. Friends of East Rock Park is a community and environmental advocacy group that encourages neighbors to meet each other, celebrate the environment, and become stewards of the park.
  • Foster Love STEM Kits: Nearly 60 remote colleagues created STEM kits to be provided to foster youth across the country. Foster Love is a non-profit organization dedicated to transforming the way youth navigate through the foster care system in America.

  • Downtown Evening Soup Kitchen (DESK): DESK’s mission is to serve people experiencing homelessness or living in poverty by providing food assistance and services that promote health, community, and equity. Eight Arvinas volunteers prepared meals to be served to members of the Greater New Haven community.

  • Boys & Girls Club of Greater New Haven: Over 20 members of Arvinas worked to enhance indoor and outdoor facilities. The Boys & Girls Club of Greater New Haven aims to “enable all young people, especially those who need us most, to reach their full potential as productive, caring, responsible citizens”.

  • Junior Achievement (JA-in-a-Day) In-Classroom Education Program: Arvinas volunteers worked alongside teachers in elementary grades educating more than 250 students in eight classes at the ACES Wintergreen Interdistrict Magnet school, which inspires learning through teaching about financial literacy, careers, and entrepreneurship.

  • Save the Sound Beach & Park Cleanups: Over 70 Arvinas team members gathered at New Haven’s Long Wharf Beach and Lighthouse Point Park to join Save the Sound, a regional non-profit organization, whose mission is to protect and improve the land, air, and water of Connecticut and the Long Island Sound region through legal and scientific expertise and by bringing people together to achieve results that benefit the environment for current and future generations. Arvinas volunteers spent nearly four hours collecting 3,369 items and more than 268 pounds of trash.  

“This day is a testament to the importance of giving back, aligning with our core values, and fostering a stronger, more inclusive community,” added Houston. “It is through our collective efforts that we can positively impact the lives of others and inspire change."

About Arvinas

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs: bavdegalutamide and ARV-766 for the treatment of men with metastatic castration-resistant prostate cancer; and vepdegestrant (ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. For more information, visit .

Arvinas Contacts

Media:

Kirsten Owens

203-584-0307

Investors:

Jeff Boyle

+1 (347) 247-5089



EN
18/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arvinas Holding

Ritika Das ... (+2)
  • Ritika Das
  • Robert Driscoll
 PRESS RELEASE

Arvinas Reports First Quarter 2025 Financial Results and Provides Corp...

Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update – Reported positive topline results from the Phase 3 VERITAC-2 trial that support global regulatory filings – – Presented first-in-human data for the Company’s first neuroscience program with ARV-102 showing blood-brain barrier penetration and central and peripheral LRRK2 degradation – – Announced the re-prioritization of its vepdegestrant development plan and research portfolio and initiated cost reductions, including a workforce reduction of approximately one-third, to extend the Company’s cash runway...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.
David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Dylan Shindler
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Yun Zhong

ResearchPool Subscriptions

Get the most out of your insights

Get in touch